Autoantibodies in normal and abnormal pregnancy.

Area of Science:

• Reproductive Immunology
• Autoimmunity
• Maternal-Fetal Medicine

Background:

• Abnormal autoimmune function is increasingly recognized as a cause of reproductive failure and pregnancy loss.
• Historically, many conditions linked to pregnancy loss are now understood to have autoimmune origins.
• The correlation between autoantibodies and pregnancy loss was only recently established.

Purpose of the Study:

• To investigate the role of polyclonal autoantibody abnormalities in reproductive failure.
• To examine the distinct control of autoantibodies during pregnancy compared to standard immunoglobulins.
• To explore the potential link between fetal antigens and elevated autoantibody levels in abnormal pregnancies.

Main Methods:

• Analysis of polyclonal autoantibody abnormalities in patients with reproductive failure.
• Comparison of autoantibody levels (specifically anti-phospholipid antibodies) in normal versus abnormal pregnancies.
• Evaluation of autoantibody patterns in relation to maternal hypertension and fetal growth retardation (IUGR).

Main Results:

• Patients with reproductive failure exhibit polyclonal autoantibody abnormalities, including non-organ-specific and organ-specific autoantibodies.
• Anti-phospholipid antibodies (aPA) show abnormally high titers in the peripartal period of abnormal pregnancies.
• Elevated autoantibody levels are observed in abnormal pregnancies, particularly those with maternal hypertension and IUGR.

Conclusions:

• Abnormal autoimmune function, characterized by polyclonal autoantibody abnormalities, is a significant factor in reproductive failure.
• Autoantibodies, especially aPA, may be elevated due to antigenic stimulation from fetal antigens during pregnancy.
• Further research is warranted to understand the distinct control mechanisms of autoantibodies in pregnancy and their impact on pregnancy outcomes.